We are live on ! Find out more
AIM

Acropolis Investment Management Portfolio holdings

AUM $2.54B
1-Year Est. Return 18.96%
This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+18.96%
3 Year Est. Return
+47.59%
5 Year Est. Return
+41.85%
10 Year Est. Return
+139%
AUM
$503M
AUM Growth
+$17.8M
Cap. Flow
+$7.08M
Cap. Flow %
1.41%
Top 10 Hldgs %
66.65%
Holding
132
New
3
Increased
52
Reduced
60
Closed
5

Sector Composition

Rank Sector Weight
1 Industrials 2.61%
2 Healthcare 2.36%
3 Technology 2.16%
4 Consumer Staples 2.13%
5 Financials 2.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
51
Elevance Health
ELV
$84.9B
$1.16M 0.23%
8,321
-813
-9% -$112K
COF icon
52
Capital One
COF
$135B
$1.14M 0.23%
15,775
+3,505
+29% +$268K
GD icon
53
General Dynamics
GD
$105B
$1.13M 0.22%
8,187
-305
-4% -$43.6K
RTX icon
54
RTX Corp
RTX
$301B
$1.12M 0.22%
18,474
-1,932
-9% -$117K
CERN
55
DELISTED
Cerner Corp
CERN
$1.09M 0.22%
18,154
-3,360
-16% -$207K
ACN icon
56
Accenture
ACN
$105B
$1.08M 0.21%
10,310
+645
+7% +$68.1K
GILD icon
57
Gilead Sciences
GILD
$162B
$1.03M 0.21%
10,230
+3,930
+62% +$409K
PG icon
58
Procter & Gamble
PG
$342B
$1.03M 0.21%
13,001
-349
-3% -$26.7K
VCSH icon
59
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.02M 0.2%
12,955
-12,585
-49% -$1M
IYW icon
60
iShares US Technology ETF
IYW
$24.8B
$1M 0.2%
37,456
-720
-2% -$19.4K
ROK icon
61
Rockwell Automation
ROK
$49.2B
$989K 0.2%
9,640
-355
-4% -$37.2K
PEP icon
62
PepsiCo
PEP
$189B
$970K 0.19%
9,711
+44
+0.5% +$4.39K
JPM icon
63
JPMorgan Chase
JPM
$947B
$944K 0.19%
14,296
+1,385
+11% +$90.2K
IYH icon
64
iShares US Healthcare ETF
IYH
$3.5B
$916K 0.18%
30,545
-2,650
-8% -$78.8K
WFM
65
DELISTED
Whole Foods Market Inc
WFM
$903K 0.18%
26,955
+10,085
+60% +$321K
KMB icon
66
Kimberly-Clark
KMB
$36.1B
$888K 0.18%
6,976
-455
-6% -$54.6K
IWB icon
67
iShares Russell 1000 ETF
IWB
$49.7B
$843K 0.17%
7,442
+3,285
+79% +$376K
MNST icon
68
Monster Beverage
MNST
$92.1B
$818K 0.16%
32,958
-3,690
-10% -$89.1K
CVS icon
69
CVS Health
CVS
$123B
$795K 0.16%
8,135
-2,525
-24% -$247K
SPIB icon
70
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$777K 0.15%
23,250
MCD icon
71
McDonald's
MCD
$196B
$755K 0.15%
6,392
-954
-13% -$107K
HD icon
72
Home Depot
HD
$349B
$750K 0.15%
5,671
+2,980
+111% +$379K
NSC icon
73
Norfolk Southern
NSC
$76.9B
$737K 0.15%
8,717
-2,420
-22% -$207K
VO icon
74
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$655K 0.13%
21,800
VOE icon
75
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$645K 0.13%
7,503
+39
+0.5% +$3.41K

Similar funds

Acropolis Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Acropolis Investment Management held 132 positions worth $503M, up 3.7% from $485M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Acropolis Investment Management's Q4 2015 filing shows 3 new, 52 increased, 60 reduced and 5 closed positions. Its largest new stake was iShares Micro-Cap ETF: 2,316 shares worth $167K. The largest sale was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $4.04M.

By sector, the portfolio is most concentrated in Industrials at 2.6% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Technology.

  • Acropolis Investment Management's largest Q4 2015 buy was iShares Micro-Cap ETF: 2,316 shares worth $167K.
  • Acropolis Investment Management added most to Vanguard Total Bond Market in Q4 2015, an estimated $3.67M increase.
  • Acropolis Investment Management's biggest Q4 2015 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $4.04M.
  • Acropolis Investment Management fully exited Baxter International in Q4 2015, selling an estimated $172K.
  • Acropolis Investment Management's ten largest holdings make up 67% of its $503M portfolio in Q4 2015.
  • Acropolis Investment Management opened 3 new positions and closed 5 in Q4 2015.
  • Acropolis Investment Management's portfolio value rose 3.7% quarter-over-quarter to $503M.

Based on Acropolis Investment Management's 13F filing for Q4 2015, filed 15 Jan 2016.